Press releases
Report for DexTechs phase IIb-study for OsteoDex is ready
6 December, 2018OsteoDex, the company ́s phase 2b-project for treatment of advanced prostate cancer, mCRPC, is reported. The study is titled “A randomised, double-blind, dose-finding, repeat dose Phase II multicentre study of […]
First result from DexTechs phase IIb-study on OsteoDex
4 October, 2018OsteoDex, the company’s phase 2b-project for treatment of advanced prostate cancer, castration resistant prostate cancer (CRPC), is finished and the first results can be reported. The study has the title […]
Positive first results in DexTechs phase IIb-study for OsteoDex
9 February, 2017The study has the title “A randomised, double-blind, dose finding, repeat dose Phase II multicentre study of ODX for the treatment of patients with castration resistant prostate cancer (CRPC) and […]
DexTech closes research agreement on glycosylation technology
2 November, 2015Press release 2015-11-02 DexTech Medical AB, 556664-6203 DexTech closes research agreement on glycosylation technology DexTech announced today that Roche and DexTech have signed a research agreement with the aim to […]